Skip to main content

Remembering a pioneer of chromatin biology

Charles David Allis, a molecular biologist who shaped the field of chromatin biology, died on January 8 at the age of 71.

Why older fathers pass on more genetic mutations to their offspring

It's not just the number of mutations that matters. It's the failure to fix them too.

>

Solving a crucial bottleneck in drug discovery

A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.

When the body's B cell training grounds stay open after hours

While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.

Intriguing science discoveries of 2022

Breakthroughs in genetics, biochemistry, neuroscience, infectious disease, and drug development were a few of the year's highlights.

Markus Library prepares researchers for new NIH data management policy

The library is offering new tools and training to support researchers operating under an updated NIH policy.

>

How a cell's mitochondria make their own protein factories

The findings shed a rare light on mitoribosomes, the unique ribosomes found within the cell's mitochondria.

How antibody therapy impacts COVID vaccines

People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.

Research on rare genetic disease sheds light on a common head and neck cancer

Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.

Cancer stem cells are fueled through dialogue with their environments

The findings suggest that many of the mutations in cancer may simply be setting in stone a path already forged by the tumor stem cell’s aberrant dialogue with its surroundings.